In an unexpected move, Johnson & Johnson, the multinational pharmaceutical giant, has informed certain US hospitals about a change in their pricing strategy for two drugs sold under the drug-savings program. Previously, these drugs were sold at discounted prices, but hospitals will now have to purchase them at full cost, following which they can claim…